Ethosuximide

Generic Name
Ethosuximide
Brand Names
Zarontin
Drug Type
Small Molecule
Chemical Formula
C7H11NO2
CAS Number
77-67-8
Unique Ingredient Identifier
5SEH9X1D1D
Background

An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.

Indication

For the treatment of petit mal epilepsy.

Associated Conditions
Petit Mal Epilepsy
Associated Therapies
-
Clinical Trials
Related News

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

Phase 2
Recruiting
Conditions
Peripheral Neuropathic Pain
Interventions
Drug: Placebo
Drug: Ethosuximide
First Posted Date
2020-06-16
Last Posted Date
2023-01-06
Lead Sponsor
University Hospital, Clermont-Ferrand
Target Recruit Count
64
Registration Number
NCT04431778
Locations
🇫🇷

Hospital of Annecy Genevois, Annecy, France

🇫🇷

Hospital University, Lyon, Lyon, France

🇫🇷

CHu Limoges, Limoges, France

and more 8 locations

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

First Posted Date
2020-01-03
Last Posted Date
2020-01-03
Lead Sponsor
Tanta University
Target Recruit Count
60
Registration Number
NCT04217733
Locations
🇪🇬

Sherief Abd-Elsalam, Tanta, Egypt

Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.

First Posted Date
2019-03-25
Last Posted Date
2022-05-20
Lead Sponsor
Zhejiang University
Target Recruit Count
16
Registration Number
NCT03887624
Locations
🇨🇳

Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Population Pharmacokinetics of Antiepileptic in Pediatrics

First Posted Date
2017-06-22
Last Posted Date
2024-10-30
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
1000
Registration Number
NCT03196466
Locations
🇫🇷

AP-HP Cochin, Paris, France

Ethosuximide to Treat IBS

First Posted Date
2016-11-25
Last Posted Date
2023-01-06
Lead Sponsor
University Hospital, Clermont-Ferrand
Target Recruit Count
162
Registration Number
NCT02973542
Locations
🇫🇷

CHU Clermont-Ferrand, Clermont-Ferrand, France

Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)

Phase 2
Completed
Conditions
Cancer
Peripheral Neuropathy
Interventions
Drug: Placebo
Drug: Ethosuximide
First Posted Date
2011-01-17
Last Posted Date
2016-05-26
Lead Sponsor
Royal Marsden NHS Foundation Trust
Target Recruit Count
15
Registration Number
NCT01278004
Locations
🇬🇧

The Royal Marsden NHS Foundation Trust, London, United Kingdom

🇬🇧

Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Comparison of a Drug and Placebo in the Prevention of Migraine Headaches

First Posted Date
2010-05-13
Last Posted Date
2015-08-19
Lead Sponsor
US Department of Veterans Affairs
Target Recruit Count
5
Registration Number
NCT01122381
Locations
🇺🇸

VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania, United States

Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)

First Posted Date
2008-06-03
Last Posted Date
2011-05-13
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Target Recruit Count
4
Registration Number
NCT00689585
Locations
🇨🇦

McGill University Health Centre, Montreal, Quebec, Canada

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

First Posted Date
2004-07-27
Last Posted Date
2020-10-14
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Target Recruit Count
453
Registration Number
NCT00088452
Locations
🇺🇸

Mattel Children's Hospital at UCLA, Los Angeles, California, United States

🇺🇸

Children's Memorial Hospital, Chicago, Illinois, United States

🇺🇸

Children's Hospital, Inc., PCTI, Columbus, Ohio, United States

and more 28 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy